Copyright Reports & Markets. All rights reserved.

Global Physiologically Active Peptides Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Physiologically Active Peptides Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Antimicrobial Peptides
    • 1.3.3 Neuroactive Peptides
    • 1.3.4 Immunoactive Peptides
    • 1.3.5 Antioxidant Peptides
    • 1.3.6 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Physiologically Active Peptides Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Food and Beverages
    • 1.4.3 Cosmetics
    • 1.4.4 Others
  • 1.5 Global Physiologically Active Peptides Market Size & Forecast
    • 1.5.1 Global Physiologically Active Peptides Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Physiologically Active Peptides Sales Quantity (2019-2030)
    • 1.5.3 Global Physiologically Active Peptides Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 American Peptide Company Inc.
    • 2.1.1 American Peptide Company Inc. Details
    • 2.1.2 American Peptide Company Inc. Major Business
    • 2.1.3 American Peptide Company Inc. Physiologically Active Peptides Product and Services
    • 2.1.4 American Peptide Company Inc. Physiologically Active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 American Peptide Company Inc. Recent Developments/Updates
  • 2.2 Phermpep Co. Ltd.
    • 2.2.1 Phermpep Co. Ltd. Details
    • 2.2.2 Phermpep Co. Ltd. Major Business
    • 2.2.3 Phermpep Co. Ltd. Physiologically Active Peptides Product and Services
    • 2.2.4 Phermpep Co. Ltd. Physiologically Active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Phermpep Co. Ltd. Recent Developments/Updates
  • 2.3 ALEXIS Corporation
    • 2.3.1 ALEXIS Corporation Details
    • 2.3.2 ALEXIS Corporation Major Business
    • 2.3.3 ALEXIS Corporation Physiologically Active Peptides Product and Services
    • 2.3.4 ALEXIS Corporation Physiologically Active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 ALEXIS Corporation Recent Developments/Updates
  • 2.4 Merck KGaA
    • 2.4.1 Merck KGaA Details
    • 2.4.2 Merck KGaA Major Business
    • 2.4.3 Merck KGaA Physiologically Active Peptides Product and Services
    • 2.4.4 Merck KGaA Physiologically Active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Merck KGaA Recent Developments/Updates
  • 2.5 Promega Corporation
    • 2.5.1 Promega Corporation Details
    • 2.5.2 Promega Corporation Major Business
    • 2.5.3 Promega Corporation Physiologically Active Peptides Product and Services
    • 2.5.4 Promega Corporation Physiologically Active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Promega Corporation Recent Developments/Updates
  • 2.6 Advanced Bioconcept Company
    • 2.6.1 Advanced Bioconcept Company Details
    • 2.6.2 Advanced Bioconcept Company Major Business
    • 2.6.3 Advanced Bioconcept Company Physiologically Active Peptides Product and Services
    • 2.6.4 Advanced Bioconcept Company Physiologically Active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Advanced Bioconcept Company Recent Developments/Updates
  • 2.7 Arlak Biotech
    • 2.7.1 Arlak Biotech Details
    • 2.7.2 Arlak Biotech Major Business
    • 2.7.3 Arlak Biotech Physiologically Active Peptides Product and Services
    • 2.7.4 Arlak Biotech Physiologically Active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Arlak Biotech Recent Developments/Updates
  • 2.8 WN Pharmaceuticals Ltd.
    • 2.8.1 WN Pharmaceuticals Ltd. Details
    • 2.8.2 WN Pharmaceuticals Ltd. Major Business
    • 2.8.3 WN Pharmaceuticals Ltd. Physiologically Active Peptides Product and Services
    • 2.8.4 WN Pharmaceuticals Ltd. Physiologically Active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 WN Pharmaceuticals Ltd. Recent Developments/Updates
  • 2.9 Anaspec Inc.
    • 2.9.1 Anaspec Inc. Details
    • 2.9.2 Anaspec Inc. Major Business
    • 2.9.3 Anaspec Inc. Physiologically Active Peptides Product and Services
    • 2.9.4 Anaspec Inc. Physiologically Active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Anaspec Inc. Recent Developments/Updates
  • 2.10 Thermo Fisher Scientific
    • 2.10.1 Thermo Fisher Scientific Details
    • 2.10.2 Thermo Fisher Scientific Major Business
    • 2.10.3 Thermo Fisher Scientific Physiologically Active Peptides Product and Services
    • 2.10.4 Thermo Fisher Scientific Physiologically Active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.11 Seagarden AS
    • 2.11.1 Seagarden AS Details
    • 2.11.2 Seagarden AS Major Business
    • 2.11.3 Seagarden AS Physiologically Active Peptides Product and Services
    • 2.11.4 Seagarden AS Physiologically Active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Seagarden AS Recent Developments/Updates
  • 2.12 Novo Nordisk A/S
    • 2.12.1 Novo Nordisk A/S Details
    • 2.12.2 Novo Nordisk A/S Major Business
    • 2.12.3 Novo Nordisk A/S Physiologically Active Peptides Product and Services
    • 2.12.4 Novo Nordisk A/S Physiologically Active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Novo Nordisk A/S Recent Developments/Updates

3 Competitive Environment: Physiologically Active Peptides by Manufacturer

  • 3.1 Global Physiologically Active Peptides Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Physiologically Active Peptides Revenue by Manufacturer (2019-2024)
  • 3.3 Global Physiologically Active Peptides Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Physiologically Active Peptides by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Physiologically Active Peptides Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Physiologically Active Peptides Manufacturer Market Share in 2023
  • 3.5 Physiologically Active Peptides Market: Overall Company Footprint Analysis
    • 3.5.1 Physiologically Active Peptides Market: Region Footprint
    • 3.5.2 Physiologically Active Peptides Market: Company Product Type Footprint
    • 3.5.3 Physiologically Active Peptides Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Physiologically Active Peptides Market Size by Region
    • 4.1.1 Global Physiologically Active Peptides Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Physiologically Active Peptides Consumption Value by Region (2019-2030)
    • 4.1.3 Global Physiologically Active Peptides Average Price by Region (2019-2030)
  • 4.2 North America Physiologically Active Peptides Consumption Value (2019-2030)
  • 4.3 Europe Physiologically Active Peptides Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Physiologically Active Peptides Consumption Value (2019-2030)
  • 4.5 South America Physiologically Active Peptides Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Physiologically Active Peptides Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Physiologically Active Peptides Sales Quantity by Type (2019-2030)
  • 5.2 Global Physiologically Active Peptides Consumption Value by Type (2019-2030)
  • 5.3 Global Physiologically Active Peptides Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Physiologically Active Peptides Sales Quantity by Application (2019-2030)
  • 6.2 Global Physiologically Active Peptides Consumption Value by Application (2019-2030)
  • 6.3 Global Physiologically Active Peptides Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Physiologically Active Peptides Sales Quantity by Type (2019-2030)
  • 7.2 North America Physiologically Active Peptides Sales Quantity by Application (2019-2030)
  • 7.3 North America Physiologically Active Peptides Market Size by Country
    • 7.3.1 North America Physiologically Active Peptides Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Physiologically Active Peptides Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Physiologically Active Peptides Sales Quantity by Type (2019-2030)
  • 8.2 Europe Physiologically Active Peptides Sales Quantity by Application (2019-2030)
  • 8.3 Europe Physiologically Active Peptides Market Size by Country
    • 8.3.1 Europe Physiologically Active Peptides Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Physiologically Active Peptides Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Physiologically Active Peptides Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Physiologically Active Peptides Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Physiologically Active Peptides Market Size by Region
    • 9.3.1 Asia-Pacific Physiologically Active Peptides Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Physiologically Active Peptides Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Physiologically Active Peptides Sales Quantity by Type (2019-2030)
  • 10.2 South America Physiologically Active Peptides Sales Quantity by Application (2019-2030)
  • 10.3 South America Physiologically Active Peptides Market Size by Country
    • 10.3.1 South America Physiologically Active Peptides Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Physiologically Active Peptides Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Physiologically Active Peptides Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Physiologically Active Peptides Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Physiologically Active Peptides Market Size by Country
    • 11.3.1 Middle East & Africa Physiologically Active Peptides Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Physiologically Active Peptides Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Physiologically Active Peptides Market Drivers
  • 12.2 Physiologically Active Peptides Market Restraints
  • 12.3 Physiologically Active Peptides Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Physiologically Active Peptides and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Physiologically Active Peptides
  • 13.3 Physiologically Active Peptides Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Physiologically Active Peptides Typical Distributors
  • 14.3 Physiologically Active Peptides Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Physiologically Active Peptides market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Physiologically Active Peptides market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Physiologically Active Peptides market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2019-2030
    Global Physiologically Active Peptides market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2019-2030
    Global Physiologically Active Peptides market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2019-2030
    Global Physiologically Active Peptides market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Physiologically Active Peptides
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Physiologically Active Peptides market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include American Peptide Company Inc., Phermpep Co. Ltd., ALEXIS Corporation, Merck KGaA, Promega Corporation, Advanced Bioconcept Company, Arlak Biotech, WN Pharmaceuticals Ltd., Anaspec Inc., Thermo Fisher Scientific, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Physiologically Active Peptides market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Antimicrobial Peptides
    Neuroactive Peptides
    Immunoactive Peptides
    Antioxidant Peptides
    Others
    Market segment by Application
    Food and Beverages
    Cosmetics
    Others
    Major players covered
    American Peptide Company Inc.
    Phermpep Co. Ltd.
    ALEXIS Corporation
    Merck KGaA
    Promega Corporation
    Advanced Bioconcept Company
    Arlak Biotech
    WN Pharmaceuticals Ltd.
    Anaspec Inc.
    Thermo Fisher Scientific
    Seagarden AS
    Novo Nordisk A/S
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Physiologically Active Peptides product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Physiologically Active Peptides, with price, sales quantity, revenue, and global market share of Physiologically Active Peptides from 2019 to 2024.
    Chapter 3, the Physiologically Active Peptides competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Physiologically Active Peptides breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Physiologically Active Peptides market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Physiologically Active Peptides.
    Chapter 14 and 15, to describe Physiologically Active Peptides sales channel, distributors, customers, research findings and conclusion.

    Buy now